CEBPZ and Recurrent lower respiratory tract infections: In cell suspensions, the anti-viral effects of intervention with SHL were greater than the effects with CBF in A549 cells but not HEp-2 cells, suggesting that SHL was a more effective drug at improving the lower respiratory tract infections in virus.